NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK‑2 cells

  • Authors:
    • Wei Dong
    • Zhilian Li
    • Yuanhan Chen
    • Li Zhang
    • Zhiming Ye
    • Huaban Liang
    • Ruizhao Li
    • Lixia Xu
    • Bin Zhang
    • Shuangxin Liu
    • Weidong  Wang
    • Chunling Li
    • Jialun Luo
    • Wei Shi
    • Xinling Liang
  • View Affiliations

  • Published online on: July 21, 2017     https://doi.org/10.3892/br.2017.948
  • Pages: 226-230
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the protective effect of the NADPH oxidase inhibitor, diphenyleneiodonium (DPI) against necroptosis in renal tubular epithelial cells. A necroptosis model of HK‑2 cells was established using tumor necrosis factor‑α, benzyloxycarbonyl‑Val‑Ala‑Asp‑fluoromethylketone and antimycin A (collectively termed TZA), as in our previous research. The necroptosis inhibitor, necrostatin‑1 (Nec‑1) or the NADPH oxidase inhibitor, DPI were administered to the necroptosis model. Production of reactive oxygen species (ROS) was detected by dichlorodihydrofluorescein diacetate in the different groups, and the manner of cell death was identified by flow cytometry. Western blot analysis was used to determine the levels of phosphorylation of receptor‑interacting protein kinase 3 (RIP‑3) and mixed lineage kinase domain‑like (MLKL), which are essential to necroptosis. The results revealed that TZA increased the percentages of propidium iodide‑positive HK‑2 cells from 1.22±0.69 to 8.98±0.73% (P<0.001), and augmented the phosphorylation of RIP‑3 and MLKL. ROS levels were increased in the TZA group compared with the control group (27.74±1.60x104 vs. 18.51±1.10x104, respectively; P<0.001), and could be inhibited by Nec‑1 (TZA + Nec‑1 group, 22.90±2.22x104 vs. TZA group, 27.74±1.60x104; P=0.01). DPI decreased ROS production (TZA + DPI group, 22.13±1.86x104 vs. TZA group, 27.74±1.60x104; P<0.001) and also reduced the proportions of necrosis in the necroptosis model (TZA + DPI group, 4.40±1.51% vs. TZA group, 8.98±0.73%; P<0.001). Phosphorylated RIP‑3 and MLKL were also decreased by DPI treatment. The results indicate that ROS production increases in HK‑2 cells undergoing necroptosis, and that the NADPH oxidase inhibitor, DPI may protect HK‑2 cells from necroptosis via inhibition of ROS production.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 7 Issue 3

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dong W, Li Z, Chen Y, Zhang L, Ye Z, Liang H, Li R, Xu L, Zhang B, Liu S, Liu S, et al: NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK‑2 cells. Biomed Rep 7: 226-230, 2017
APA
Dong, W., Li, Z., Chen, Y., Zhang, L., Ye, Z., Liang, H. ... Liang, X. (2017). NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK‑2 cells. Biomedical Reports, 7, 226-230. https://doi.org/10.3892/br.2017.948
MLA
Dong, W., Li, Z., Chen, Y., Zhang, L., Ye, Z., Liang, H., Li, R., Xu, L., Zhang, B., Liu, S., Wang, W., Li, C., Luo, J., Shi, W., Liang, X."NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK‑2 cells". Biomedical Reports 7.3 (2017): 226-230.
Chicago
Dong, W., Li, Z., Chen, Y., Zhang, L., Ye, Z., Liang, H., Li, R., Xu, L., Zhang, B., Liu, S., Wang, W., Li, C., Luo, J., Shi, W., Liang, X."NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK‑2 cells". Biomedical Reports 7, no. 3 (2017): 226-230. https://doi.org/10.3892/br.2017.948